Treatment of neck and shoulder pain in whip-lash syndrome patients with intracutaneous sterile water injections.
Ten whip-lash syndrome patients treated with intracutaneous triggerpoint injections with sterile water for pain relief were followed for 2 months. Pain intensity was evaluated with the Visual Analogue Scale (VAS). Eight patients became free from pain (VAS 0) and two patients improved to VAS 2 immediately after the treatment. Nine patients remained free from pain, three of them after one treatment, while six patients needed 2-4 treatments. One patient responded only a few hours after each of three treatments. Remarkably, with the relief of pain mobility was normalised in all patients. The method is suggested to be a first choice in the treatment of not only whip-lash patients but also for most acute and chronic musculo-skeletal triggerpoint pain syndromes.
Byrn
C
C
Department of Anesthesiology and Intensive Care, Sahlgren's Hospital University of Gothenburg, Sweden.
Borenstein
P
P
Linder
L E
LE
D000328:Adult; D005260:Female; D006801:Humans; D007271:Injections, Intradermal; D008297:Male; D008875:Middle Aged; D009209:Myofascial Pain Syndromes / Q000209:etiology / Q000628:therapy*; D014867:Water / Q000008:administration & dosage / Q000627:therapeutic use*; D014911:Whiplash Injuries / Q000503:physiopathology*
D014867:Water